Punthakee Zubin, Delvin Edgard E, O'loughlin Jennifer, Paradis Gilles, Levy Emile, Platt Robert W, Lambert Marie
Medical Genetics Service, Ste-Justine Hospital, 3175 Côte-Sainte-Catherine, Montréal, Québec, Canada.
J Clin Endocrinol Metab. 2006 Jun;91(6):2119-25. doi: 10.1210/jc.2005-2346. Epub 2006 Mar 14.
Determinants of adiponectin and its association with insulin resistance (IR) are less well studied in youth than in adults.
The objective of the study was to describe, in youth, the age- and sex-specific distribution of adiponectin concentrations and the association with demographic, anthropometric, and lifestyle factors, parental diabetes, and markers of IR.
DESIGN, SETTING, PARTICIPANTS: We studied 1632 French Canadian youth aged 9, 13, and 16 yr who participated in the Québec Child and Adolescent Health and Social Survey, a province-wide, school-based survey conducted in 1999.
Boys had lower adiponectin concentrations than girls by 17% (P < 0.0001). At age 16 yr, mean adiponectin concentrations were 27.7% (boys, P < 0.0001) and 13.3% (girls, P < 0.0001) lower than at age 9 yr (p(interaction) = 0.009). Mean adiponectin decreased for every unit increase in body mass index (BMI) Z-score by 8.1% in boys and 11.2% in girls (P < 0.0001). Growth-related change in BMI explained half the age effect in boys and all the age effect in girls. Self-reported pubertal status, physical activity, smoking, and parental diabetes were not independently associated with adiponectin. Fasting insulin and homeostasis model assessment-IR were not associated with adiponectin concentration. However, the interaction of adiponectin and BMI Z-score was significant in a multiple regression model of fasting insulin.
Male sex and changes in body fat may be major determinants of the decreasing adiponectin concentrations of growing youth, which are accompanied by a dissociation of adiponectin and markers of IR. The relationship between adiposity and markers of IR is attenuated in those with higher adiponectin concentrations, making adiponectin a potential intervention target or risk marker.
与成年人相比,青少年中脂联素的决定因素及其与胰岛素抵抗(IR)的关联研究较少。
本研究的目的是描述青少年中脂联素浓度的年龄和性别特异性分布,以及与人口统计学、人体测量学和生活方式因素、父母患糖尿病情况及IR标志物的关联。
设计、地点、参与者:我们研究了1632名年龄分别为9岁、13岁和16岁的法裔加拿大青少年,他们参与了1999年在魁北克全省范围内开展的基于学校的魁北克儿童和青少年健康与社会调查。
男孩的脂联素浓度比女孩低17%(P<0.0001)。16岁时,平均脂联素浓度比9岁时分别降低了27.7%(男孩,P<0.0001)和13.3%(女孩,P<0.0001)(交互作用P=0.009)。男孩和女孩的平均脂联素水平随体重指数(BMI)Z评分每增加一个单位分别下降8.1%和11.2%(P<0.0001)。BMI与生长相关的变化解释了男孩年龄效应的一半和女孩所有的年龄效应。自我报告的青春期状态、体育活动、吸烟及父母患糖尿病情况与脂联素无独立关联。空腹胰岛素和稳态模型评估-IR与脂联素浓度无关。然而,在空腹胰岛素的多元回归模型中,脂联素与BMI Z评分的交互作用显著。
男性性别和体脂变化可能是青少年生长过程中脂联素浓度降低的主要决定因素,并伴随着脂联素与IR标志物的分离。在脂联素浓度较高的人群中,肥胖与IR标志物之间的关系减弱,这使得脂联素成为一个潜在的干预靶点或风险标志物。